Menovo receives European CEP certificate for venlafaxine hydrochloride API

November 20, 2026  Source: drugdu 41

"/
On November 19, Menovo disclosed that it had received a Certificate of Suitability to the monographs of the European Pharmacopoeia (CEP) for its venlafaxine hydrochloride API from the European Directorate for the Quality of Medicines & HealthCare (EDQM).

Source: http://finance.eastmoney.com/a/202611193935180661.html

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.